Skip to main content

Month: September 2020

CohBar to Present at the H.C. Wainwright Annual Global Investment Conference

MENLO PARK, Calif., Sept. 03, 2020 (GLOBE NEWSWIRE) — CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and extend healthy lifespan, announced today that its Chief Executive Officer, Steven Engle, will present a company update at the H.C. Wainwright Annual Global Investment Conference, being held virtually on September 14-16, 2020.About CohBarCohBar (NASDAQ: CWBR) is a clinical stage biotechnology company focused on the research and development of mitochondria based therapeutics, an emerging class of drugs for the treatment of chronic and age-related diseases. Mitochondria based therapeutics originate from the discovery by CohBar’s founders of a novel group of naturally occurring peptide sequences within the mitochondrial genome, some of which have...

Continue reading

George Pedersen Transitions to Chairman Emeritus; ManTech Board of Directors Elects Kevin Phillips as Chairman of the Board

HERNDON, Va., Sept. 03, 2020 (GLOBE NEWSWIRE) — ManTech (Nasdaq: MANT) announced today that its co-founder, George J. Pedersen, has decided to transition from his role as Executive Chairman and Chairman of the Board. Pedersen will remain a member of the Board of Directors, serving with the distinction of Chairman Emeritus of ManTech. Kevin M. Phillips, who has served as the Company’s President and Chief Executive Officer since January 2018, has been elected by the Board to serve as the Company’s Chairman of the Board.“For the past five decades, ManTech has been an important part of my life and it will always remain so,” Pedersen said. “It has been a pleasure for me to see the tremendous growth of ManTech since our humble beginnings in New Jersey as Management Technology, back in 1968, where we started with a single Navy contract...

Continue reading

Loncor Increases Interest in Adumbi Mining to 84.68%

TORONTO, Sept. 03, 2020 (GLOBE NEWSWIRE) — Loncor Resources Inc. (“Loncor” or the “Company“) (TSX: “LN”; OTCQX: “LONCF”; FSE: “LO51”) reports that its subsidiary, Adumbi Mining, has been restructured as per the requirements of the OHADA (Organization for the Harmonization of Business Law in Africa) Uniform Act relating to commercial companies.  OHADA Uniform Acts provide for a system of common business laws which have been adopted by seventeen West and Central African countries, including the Democratic Republic of the Congo (the “DRC”).  The restructuring has resulted in Loncor increasing its interest in Adumbi Mining to 84.68%, minority shareholders holding 5.32% and the DRC 10%.  The DRC was allocated 10% in accordance with the requirements of the new DRC Mining Code enacted...

Continue reading

Duluth Holdings Inc. Announces Second Quarter Fiscal 2020 Financial Results

MOUNT HOREB, Wis., Sept. 03, 2020 (GLOBE NEWSWIRE) — Duluth Holdings Inc. (dba, Duluth Trading Company) (“Duluth Trading” or the “Company”) (NASDAQ: DLTH), a lifestyle brand of men’s and women’s casual wear, workwear and accessories, today announced its financial results for the fiscal second quarter ended August 2, 2020.Highlights for the Second Quarter Ended August 2, 2020Net sales increased 12.6% to $137.4 million compared to $122.0 million in the prior-year second quarterDirect-to-consumer net sales increased 66.9% and retail store net sales decreased 40.4% as stores re-opened throughout the first half of the quarterGross margin decreased to 52.8% compared to 53.1% in the prior-year second quarterOperating income increased to $9.8 million compared to operating income of $3.7 million in the prior-year second quarterNet income...

Continue reading

DZS Teams with Nimbus Networks to Bring Hyper-Connectivity and Contactless Solutions to the Hospitality Market in Latin America

PLANO, Texas, Sept. 03, 2020 (GLOBE NEWSWIRE) — DZS (NASDAQ: DZSI), a leading enabler of the hyper-connected world, has partnered with Nimbus Networks, an innovative IT integrator and leader in fiber, cloud, and managed services for the hospitality industry, to deliver a cutting-edge hyper-connected experience to over 20 high-end hotels across Latin America. By leveraging DZS FiberLAN technology, a state-of-the-art fiber optic and Wi-Fi infrastructure, and unique applications like Nimbus unique cloud based services, these hotels are revolutionizing the hospitality industry by raising the bar on customer expectations when they stay at Nimbus-enabled hotels.The DZS FiberLAN solutions leveraged by Nimbus utilize multi-gigabit capable GPON technology on the MXK-F OLT and Z-Series ONTs and wireless access points featuring world-class...

Continue reading

Todos Medical Announces August Sales of $1,190,000, Up 100% Compared with July

NEW YORK, REHOVOT, Israel and SINGAPORE, Sept. 03, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Todos Medical Ltd. (OTCQB: TOMDF), an in vitro diagnostics company focused on distributing comprehensive solutions for COVID-19 screening and diagnosis, and developing blood tests for the early detection of cancer and Alzheimer’s disease, today announced sales for the month of August 2020 were $1,190,000. This compares with sales for the month of July 2020 of $550,000, with growth driven by week-over-week increases in demand for extraction reagents and automated extraction equipment.During August, Todos also signed sales contracts with laboratories in New York, Texas and Wisconsin with a total value of more than $35 million and the right to supply up to 280,000 COVID-19 PCR tests per day.  Todos also entered into a common stock purchase...

Continue reading

EDAP Announces First Patients Treated in Phase 2 Study of Focal One for the Treatment of Deep Invasive Endometriosis

      ·  First patients already treated as recruitment acceleratesLYON, France, September 3, 2020 — EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced that the first two patients have been treated in the company’s Phase 2 clinical trial assessing Focal One® High Intensity Focused Ultrasound (HIFU) as a potential treatment for deep rectal endometriosis. A total of 38 women will be enrolled in the study and treated at five major hospitals and assessed over a six-month follow-up period. Follow-up of these patients will evaluate the safety and efficacy of HIFU for this pathology. Additional patients continue to be enrolled.Pr. Gil Dubernard, Head of the Gynecologic Department, Croix-Rousse University Hospital, Lyon, and lead investigator, commented, “The first two patient treatments were...

Continue reading

TomTom Launches RoadCheck: A Pioneering Product for Safer Autonomous Driving

RoadCheck – an industry first technology – allows carmakers to manage where it is safe for drivers to activate automated driving functionsTomTom strengthens its claim as the most complete mapping service supplier for safe driving automationAMSTERDAM, The Netherlands, Sept. 03, 2020 (GLOBE NEWSWIRE) — TomTom (TOM2), the leading independent location technology specialist, today launched TomTom RoadCheck, a pioneering product for automated vehicles that allows carmakers to decide where it is safe for drivers to activate their vehicles’ automated driving functions.Safe automated driving is not always possible during periods of adverse weather, in tunnels, and in changing environments, such as during roadworks. RoadCheck enables carmakers to use TomTom’s high definition (HD) map data to define the operational design domain (ODD) of their...

Continue reading

Cue Biopharma to Present at Upcoming Investor Conferences in September 2020

CAMBRIDGE, Mass., Sept. 03, 2020 (GLOBE NEWSWIRE) — Cue Biopharma, Inc. (NASDAQ: CUE), a clinical-stage biopharmaceutical company engineering a novel class of injectable biologics to selectively engage and modulate targeted T cells within the body, announced today it will present at the Baird Global Healthcare Conference on Wednesday, September 9, 2020, the Morgan Stanley Global Healthcare Conference on Thursday, September 17, 2020 and the Oppenheimer & Co. Fall Healthcare Life Sciences and MedTech Summit on Wednesday, September 23, 2020. The Company will also participate in Citi’s 15th Annual BioPharma Virtual Conference on September 9-10, 2020.Cue Biopharma will provide an overview highlighting the Immuno-STAT™ (Selective Targeting and Alteration of T cells) platform and its next-generation Neo-STAT™. The presentations...

Continue reading

Ackroo to hold 2020 Annual General Meeting on October 8th

HAMILTON, Ontario, Sept. 03, 2020 (GLOBE NEWSWIRE) — Ackroo Inc. (TSX-V: AKR; OTC: AKRFF) (the “Company”), a loyalty marketing, gift card and payments technology and services provider, is pleased to announce that its annual general and special meeting of shareholders will be held on October 8, 2020 at 2:00 p.m. (Eastern Time). The meeting will be held in a hybrid format in which shareholders will be invited to join a live audio conference with management of the Company. At the meeting, management will be available to answer questions regarding the ongoing business of the Company, and interested shareholders are invited to attend.Further information on the format of the meeting and matters to be considered at the meeting will be made available in the management information circular which will be mailed to shareholders of record as...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.